LIVE MARKET TRACKER :   BSE SENSEX   31138.21      |    NSE NIFTY 9574.95    
GLOBAL MARKETS :  NASDAQ 6265.2495   +0.4580%    |    FSI London 7424.13   -0.20%    |    NIKKEI Japan 20162.21   +0.15%
  USD GBP EUR CAD AUD INR
USD - 0.7845 0.8937 1.3258 1.3208 64.5300
GBP 1.2749 - 1.1392 1.6902 1.6837 82.2590
EUR 1.1192 0.8780 - 1.4839 1.4782 72.1975
CAD 0.7544 0.5921 0.6741 - 0.9967 48.6740
AUD 0.7573 0.5941 0.6767 1.0041 - 48.8380
INR 0.0155 0.0122 0.0139 0.0206 0.0205 -
Indian-Commodity  :  Equity & Shares  :  Dr. Reddy's Laboratories gains on launching Bupropion HCI Tablets in US market

Dr. Reddy's Laboratories gains on launching Bupropion HCI Tablets in US market (06-Sep-2016)

Dr. Reddy's Laboratories is currently trading at Rs. 3137.05, up by 14.40 points or 0.46% from its previous closing of Rs. 3122.65 on the BSE.

The scrip opened at Rs. 3123.00 and has touched a high and low of Rs. 3142.85 and Rs. 3123.00 respectively.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4382.95 on 20-Oct-2015 and a 52 week low of Rs. 2750.00 on 21-Jan-2016.

Last one week high and low of the scrip stood at Rs. 3142.85 and Rs. 3019.00 respectively. The current market cap of the company is Rs. 51,959.00 crore.

The promoters holding in the company stood at 26.37%, while Institutions and Non-Institutions held 41.16% and 15.64% respectively.

Dr. Reddy's Laboratories has launched Bupropion HCI extended-release tablets, USP (SR) in 100 mg, 150 mg and 200 mg, a therapeutic equivalent generic version of Wellbutrin SR (bupropion HCI) Sustained-Release Tablets in the United States market approved by the US Food & Drug Administration (USFDA). Dr. Reddy's Buproprion SR tablets are available in 100 mg, 150 mg and 200 mg, in bottle count sizes of 60, 100 and 500.

Wellbutrin SR is a registered trademark of the GSK group of companies. The Wellbutrin SR brand and generic had US sales of approximately $109.6 million MAT for the most recent twelve months ending in July 2016, according to IMS Health.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It is committed to provide affordable and innovative medicines for healthier lives.  It manufactures and markets a wide range of pharmaceuticals in India and overseas.



Top News Today
Tata Steel sells stake in Tata Motors
(24-Jun-2017)

Tata Steel sells stake in Tata MotorsTata Steel has sold its stake in Tata Motors to Tata Sons, the holding company of India's salt-to-software Tata conglomerate, for Rs 37.83 billion ($586.3 million). The steelmaker has sold about 83.54......click on news to read complete article.

Crest Ventures acquires 6 lakh shares of Crest Wealth Management
(24-Jun-2017)

Crest Ventures acquires 6 lakh shares of Crest Wealth ManagementCrest Ventures (CVL) has acquired 6 lakh equity shares of Crest Wealth Management (CWMPL), its Subsidiary Company, from Mitesh Shah at a total consideration of Rs 43.20 lakh on June 23, 2017. Consequent......click on news to read complete article.

DPSC's arm to co-develop 12MW of solar assets in Uttarakhand
(24-Jun-2017)

DPSCDPSC's wholly owned subsidiary India Power Green Utility (IPGUPL) has agreed to co-develop 12MW of solar assets in Uttarakhand with Punj Lloyd Infrastructure (PLIL) to be executed by PL Surya Vidyut, the......click on news to read complete article.

International Stock News
US markets end mostly in green of Friday
(24-Jun-2017)

US markets end mostly in green of FridayThe US markets ended the choppy day of trade mostly in green on Friday, as traders took some support with report from the Commerce Department showing a rebound in new home sales in the month of May. The......click on news to read complete article.

US markets closed mostly lower on Thursday
(23-Jun-2017)

US markets closed mostly lower on ThursdayThe US markets closed mostly lower on Thursday, as weak financials and consumer staples shares eclipsed a rally in the health-care and biotechnology sectors. The Federal Reserve said that the 34 largest......click on news to read complete article.

US markets closed mostly lower; Nasdaq post moderate gains
(22-Jun-2017)

US markets closed mostly lower; Nasdaq post moderate gainsThe US markets closed lower on Wednesday, weighed down by losses in the energy sector as oil prices continued to slide. But the Nasdaq Composite posted moderate gains, thanks to a surge in biotechnology......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.